{{Rsnum
|rsid=5789
|Gene=PTGS1
|Chromosome=9
|position=122381694
|Orientation=plus
|GMAF=0.01745
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;C)
|geno3=(C;C)
|Gene_s=PTGS1
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;C)
| geno3=(C;C)
| CEU | 0.0 | 6.2 | 93.8
| HCB | 0.0 | 0.0 | 100.0
| JPT | 0.0 | 0.0 | 100.0
| YRI | 0.0 | 0.0 | 100.0
| ASW | 0.0 | 0.0 | 0.0
| CHB | 0.0 | 0.0 | 100.0
| CHD | 0.0 | 0.0 | 0.0
| GIH | 1.0 | 2.0 | 97.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 8.6 | 91.4
| MKK | 0.0 | 9.0 | 91.0
| TSI | 0.0 | 5.9 | 94.1
| HapMapRevision=28
}}{{PMID Auto
|PMID=20214591
|Title=Pharmacogenomics in aspirin intolerance
}}

{{PMID Auto
|PMID=17301694
|Title=Identification and functional characterization of polymorphisms in human cyclooxygenase-1 (PTGS1).
|OA=1
}}

{{PMID Auto
|PMID=17495879
|Title=Cyclooxygenase polymorphisms and risk of cardiovascular events: the Atherosclerosis Risk in Communities (ARIC) study.
|OA=1
}}

{{PMID Auto
|PMID=21097517
|Title=Neurovascular coupling in the human visual cortex is modulated by cyclooxygenase-1 (COX-1) gene variant.
}}

{{PMID Auto
|PMID=23029430
|Title=Prognostic role of host cyclooxygenase and cytokine genotypes in a Caucasian cohort of patients with gastric adenocarcinoma.
|OA=1
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | FTDNA}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}